{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:06:49Z","timestamp":1768550809840,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:00:00Z","timestamp":1375747200000},"content-version":"vor","delay-in-days":217,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Mycology Case Reports"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1016\/j.mmcr.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T22:17:37Z","timestamp":1371680257000},"page":"134-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic drug monitoring in voriconazole-associated hyponatremia"],"prefix":"10.1016","volume":"2","author":[{"given":"Ren-ai","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang-li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-ding","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-xi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mmcr.2013.06.003_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11908-010-0132-1","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease","volume":"12","author":"Ader","year":"2010","journal-title":"Current Infectious Disease Reports"},{"issue":"3","key":"10.1016\/j.mmcr.2013.06.003_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1016\/j.mmcr.2013.06.003_bib3","first-page":"489","article-title":"[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy]","volume":"45","author":"Isobe","year":"2007","journal-title":"Nihon Koky\u016bki Gakkai zasshi"},{"issue":"4","key":"10.1016\/j.mmcr.2013.06.003_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10157-010-0305-0","article-title":"Voriconazole-associated salt-losing nephropathy","volume":"14","author":"Teranishi","year":"2010","journal-title":"Clinical and Experimental Nephrology"},{"issue":"1","key":"10.1016\/j.mmcr.2013.06.003_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/13693786.2011.587210","article-title":"Voriconazole-associated severe hyponatremia","volume":"50","author":"Kim","year":"2012","journal-title":"Medical Mycology"},{"issue":"8","key":"10.1016\/j.mmcr.2013.06.003_bib6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1016\/j.mmcr.2013.06.003_bib7","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/AAC.00626-12","article-title":"Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring","volume":"56","author":"Dolton","year":"2012","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"5","key":"10.1016\/j.mmcr.2013.06.003_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/13693780310001656786","article-title":"Identification system for the genus Aspergillus and three major pathogenic species: Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger","volume":"42","author":"Sugita","year":"2004","journal-title":"Medical Mycology"},{"issue":"8","key":"10.1016\/j.mmcr.2013.06.003_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1086\/424662","article-title":"Adverse reactions to voriconazole","volume":"39","author":"Boyd","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.mmcr.2013.06.003_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740330903485637","article-title":"Voriconazole therapeutic drug monitoring: focus on safety","volume":"9","author":"Pasqualotto","year":"2010","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10.1016\/j.mmcr.2013.06.003_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/648679","article-title":"Voriconazole pharmacokinetics and pharmacodynamics in children","volume":"50","author":"Neely","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.mmcr.2013.06.003_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.mmcr.2013.06.003_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/INF.0b013e3182566311","article-title":"Voriconazole-induced phototoxicity in children","volume":"31","author":"Bernhard","year":"2012","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1016\/j.mmcr.2013.06.003_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/dmd.31.5.540","article-title":"Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole","volume":"31","author":"Hyland","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.mmcr.2013.06.003_bib15","article-title":"Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers","author":"Lee","year":"2011","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.mmcr.2013.06.003_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FTD.0b013e318167d0e0","article-title":"Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations","volume":"30","author":"Smith","year":"2008","journal-title":"Therapeutic Drug Monitoring"}],"container-title":["Medical Mycology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753913000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753913000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T05:22:31Z","timestamp":1539580951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211753913000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":16,"alternative-id":["S2211753913000419"],"URL":"https:\/\/doi.org\/10.1016\/j.mmcr.2013.06.003","relation":{},"ISSN":["2211-7539"],"issn-type":[{"value":"2211-7539","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic drug monitoring in voriconazole-associated hyponatremia","name":"articletitle","label":"Article Title"},{"value":"Medical Mycology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmcr.2013.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Human and Animal Mycology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}